financetom
Business
financetom
/
Business
/
What's Going On With Telecommunication Company Vodafone's Shares On Monday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Telecommunication Company Vodafone's Shares On Monday?
Jul 22, 2024 5:11 AM

Vodafone Group Plc ( VOD ) shares are trading higher in premarket today. The telecommunications company has sold an additional 10% stake in Oak Holdings GmbH, the partnership co-controlling Vantage Towers, for 1.3 billion euros ($1.4 billion).

This sale finalizes the 50:50 joint ownership structure with the consortium led by Global Infrastructure Partners and KKR & Co ( KKR ) .

Vodafone will receive €1.3 billion from this transaction, sold at €32 per share, matching the initial deal announced on November 9, 2022, bringing the total proceeds from selling Vantage Towers shares to €6.6 billion.

The proceeds will be used to reduce Vodafone’s debt, lowering the Net Debt/Adjusted EBITDAaL by 0.1x.

This aligns with Vodafone’s goal to operate within the lower half of its 2.25x – 2.75x leverage range.

Also Read: Vodafone Offloads India’s Indus Towers Stake To Trim $2.3B Debt

Since taking over as CEO, Margherita Della Valle has aimed to streamline Vodafone’s operations. Her strategy includes selling underperforming markets and attempting a merger with CK Hutchison’s Three, currently under U.K. competition review, reported Bloomberg.

European telecom operators, including Vodafone, are finding innovative ways to generate revenue amid challenging capital investment returns, with many opting to sell parts of their infrastructure.

Vodafone stock has lost about 8% in the last 12 months. Investors can gain exposure to the stock via First Trust NASDAQ Technology Dividend Index Fund ( TDIV ) and Pacer Global Cash Cows Dividend ETF .

Price Action: VOD shares are trading higher by 1.11% at $9.13 in premarket at last check Monday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Quantum BioPharma Receives Australian Ethics Committee Approval for Phase 2 FSD202 Trial
Quantum BioPharma Receives Australian Ethics Committee Approval for Phase 2 FSD202 Trial
May 28, 2025
08:49 AM EDT, 05/28/2025 (MT Newswires) -- Quantum BioPharma ( QNTM ) on Wednesday said it has received approval by the human ethics review committee (HREC) in Australia for its Phase 2 trial assessing its compound FSD202 for treating nociplastic pain associated with idiopathic mast cell activation syndrome. The trial will run for 56 days and enroll 60 patients with...
China tells Morgan Stanley it welcomes more US financial institutions, Xinhua reports
China tells Morgan Stanley it welcomes more US financial institutions, Xinhua reports
May 28, 2025
BEIJING, May 28 (Reuters) - China's Vice Premier He Lifeng told Morgan Stanley Co-President Daniel Simkowitz that Beijing welcomes more U.S. financial institutions and long-term capital to deepen cooperation, the official Xinhua news agency reported. He said at a meeting in Beijing that U.S. financial institutions, including Morgan Stanley ( MS ), are welcomed to actively participate in the development...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
iTeos Therapeutics to Wind Down Operations
iTeos Therapeutics to Wind Down Operations
May 28, 2025
08:49 AM EDT, 05/28/2025 (MT Newswires) -- iTeos Therapeutics ( ITOS ) said Wednesday it intends to wind down operations after a strategic review of its development pipeline, business prospects, and financial position. iTeos plans to focus on leveraging its cash balance to deliver near-term value to shareholders, including any proceeds from the potential sale of its intellectual property and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved